A study evaluating safety of dabrafenib and trametinib in advanced melanoma
Latest Information Update: 11 Aug 2021
At a glance
- Drugs Dabrafenib (Primary) ; Trametinib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 11 Aug 2021 New trial record